Antibacterial drugs refer to the substances that can destroy or inhibit the growth of microorganism such as bacteria. Antibacterial drugs are often termed as antibiotics, and widely used in prevention and treatment of infectious dieses. Various classes of these drugs have been developed, according to the microorganism to be checked. Antibacterial drugs market is driven by increasing prevalence of infectious diseases.
This report contains market size and forecasts of Antibacterial Drugs in global, including the following market information:
- Global Antibacterial Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Antibacterial Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Antibacterial Drugs companies in 2021 (%)
The global Antibacterial Drugs market was valued at 48180 million in 2021 and is projected to reach US$ 53510 million by 2028, at a CAGR of 1.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cephalosporins Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antibacterial Drugs include Sanofi, Allergan, GSK, Merck, Pfizer, Sandoz, Teva Pharmaceuticals, Abbott and Johnson & Johnson and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Antibacterial Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antibacterial Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Antibacterial Drugs Market Segment Percentages, by Type, 2021 (%)
- Cephalosporins
- Penicillins
- Fluoroquinolones
- Macrolides
- Carbapenems
- Others
Global Antibacterial Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Antibacterial Drugs Market Segment Percentages, by Application, 2021 (%)
Global Antibacterial Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Antibacterial Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Antibacterial Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Antibacterial Drugs revenues share in global market, 2021 (%)
- Key companies Antibacterial Drugs sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Antibacterial Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Sanofi
- Allergan
- GSK
- Merck
- Pfizer
- Sandoz
- Teva Pharmaceuticals
- Abbott
- Johnson & Johnson
- Eli Lilly
